1. OC-0466 Clinical value of dual energy CT based delineation in the treatment planning for prostate patients. (May 2022) Authors: Mortensen, H.K.; Mathisen, M.P.R.; Mortensen, J.; Lindberg, H.; Mouritsen, L.S.; Dohn, L.H.; Edmund, J.M. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 34LBA Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: A multinational randomised, placebo-controlled, double-blind trial – the GAND-emesis study. (September 2015) Authors: Ruhlmann, C.H.; Christensen, T.B.; Dohn, L.H.; Paludan, M.; Rannengart, E.; Hilpert, F.; Feyer, P.; Kristensen, G.; Keefe, D.; Hansen, O.; Herrstedt, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗